EDUCATION CENTER

Tesamorelin Guide

A patient-friendly education resource for clinician-guided tesamorelin therapy.

What is tesamorelin?

Tesamorelin is a growth hormone–releasing hormone (GHRH) analog used in clinician-guided protocols, including discussions around visceral adipose tissue and body-composition goals.

At Vita Bella, tesamorelin is prescribed only after licensed provider review of goals, labs, and risk.

How it may work

Tesamorelin stimulates pituitary growth hormone release, influencing IGF-1 and metabolic pathways related to fat distribution and recovery.

It is not a free pass on nutrition or training. Lifestyle foundations still drive outcomes.

Potential uses

Clinicians may discuss tesamorelin for visceral fat reduction goals, recovery support, or related body-composition targets when appropriate.

Your provider may compare it with sermorelin or other peptide options based on labs and priorities.

Candidate assessment

Candidates are typically adults with clinician-guided metabolic or recovery goals after evaluation.

Active malignancy concerns, uncontrolled diabetes, pregnancy, or other red flags may exclude therapy.

Labs & evaluation

Evaluation may include IGF-1, glucose/HbA1c, lipids, and other markers your clinician selects.

Imaging or waist/visceral-fat context may inform goals but is not always required.

Forms & dosing

Tesamorelin is typically a subcutaneous injectable with individualized dosing and schedule.

Reconstitution and storage follow pharmacy instructions — do not improvise with internet “peptide stacks.”

Injection guidance

Use sterile technique, rotate abdominal or other approved sites, and review Vita Bella injection resources.

Consistency and correct units matter more than increasing dose on your own.

Side effects

Possible effects include injection-site reactions, fluid retention, joint discomfort, or glucose changes.

Report severe edema, vision changes, or symptoms of hyperglycemia promptly.

Safety considerations

Discuss cancer history, diabetes risk, and concurrent GH-axis therapies before starting.

Quality compounding and clinician monitoring are essential.

FAQs

Tesamorelin vs sermorelin — which should I choose?

Both act on the GH axis but have different clinical profiles and use cases. Your Vita Bella provider matches the peptide to labs and goals.

Will tesamorelin burn belly fat automatically?

Some clinical contexts study visceral fat changes, but results are not guaranteed and lifestyle still matters. Set expectations with your clinician.

Can I stack tesamorelin with BPC-157?

Sometimes in clinician-designed recovery plans. Stacking without supervision increases risk and confusion about what is working.

References

  1. 1. Falutz J, et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. N Engl J Med. 2007;357:2359-2370.

  2. 2. U.S. Food and Drug Administration. Egrifta (tesamorelin) prescribing information.

Curious whether tesamorelin fits your plan?

Start with a Vita Bella membership consultation so a licensed provider can review labs, body-composition goals, and whether tesamorelin or another peptide pathway is right for you.